(1R,2S)-VU0155041
CAS No. 1263273-14-8
(1R,2S)-VU0155041 ( —— )
产品货号. M26526 CAS No. 1263273-14-8
(1R,2S)-VU0155041 是 mGluR4 的部分激动剂(EC50 为 2.35 μM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥332 | 有现货 |
|
| 5MG | ¥543 | 有现货 |
|
| 10MG | ¥794 | 有现货 |
|
| 25MG | ¥1758 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称(1R,2S)-VU0155041
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述(1R,2S)-VU0155041 是 mGluR4 的部分激动剂(EC50 为 2.35 μM)。
-
产品描述(1R,2S)-VU0155041 is a partial agonist of mGluR4(EC50 of 2.35 μM).(In Vitro):(1R,2S)-VU0155041 is similar in potency with VU0155041 At both human and rat receptors (798 nM at human mGluR4 and 693 nM at rat mGluR4). (1R,2S)-VU0155041 (30 μM) induces concentration-dependent shifts in the baseline when examined in fold shift experiments using the thallium flux assay.
-
体外实验At both human and rat receptors, the Cis regioisomer of VU0155041 is similar in potency (798±58 nM at human mGluR4 and 693±140 nM at rat mGluR4). Conversely, the concentration-response curve for the Trans regioisomer (VU0155040) does not plateau at the maximum concentration tested. Fold-shift experiments at 30 μM of VU0155041 also shows that the Cis regioisomer is more effective at this concentration on both human and rat mGluR4. VU0155041, induces concentration-dependent shifts in the baseline when examined in fold shift experiments using the thallium flux assay. VU0155041 induces a response that reaches approximately 45% of the maximal glutamate response. VU0155041is a partial agonist of mGluR4 that activates the receptor by interacting with a site that is distinct from the glutamate binding site. VU0155041 exhibitsselectivity for mGluR4 relative to 67 different targets and does not affect the function of striatal NMDA receptors.
-
体内实验VU0155041 is soluble in an aqueous vehicle and intracerebroventricular administration of 31 to 316 nM of VU0155041 dose-dependently decreases haloperidol-induced catalepsy and reserpine-induced akinesia in rats. VU0155041, at doses of 31 and 92 nmol, is also able to significantly decrease the cataleptic effects of haloperidol, and the effects of the compound are still present 30 min after infusion. Icv infusion of a 316 nmol dose of VU0155041 also results in a significant reversal of akinesia.
-
同义词——
-
通路Cell Cycle/DNA Damage
-
靶点ROCK
-
受体TRPM3
-
研究领域——
-
适应症——
化学信息
-
CAS Number1263273-14-8
-
分子量316.18
-
分子式C14H15Cl2NO3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (158.14 mM)
-
SMILESO=C([C@H]1[C@@H](C(NC2=CC(Cl)=CC(Cl)=C2)=O)CCCC1)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.I Straub, et al. Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3. Br J Pharmacol. 2013 Apr;168(8):1835-50.
产品手册
关联产品
-
Orexin 2 Receptor Ag...
Orexin 2 Receptor Agonist 是一种有效 (EC50: 23 nM) 和 OX2R 选择性(OX1R/OX2R EC50 比率:70)激动剂。
-
Narciclasine
Narciclasine 是一种天然产物,可调节 Rho/Rho-kinase/LIM 激酶/cofilin 信号通路,大大提高 GTPase RhoA 活性。
-
Ripasudil free base
Ripasudil 游离碱是一种选择性强效 ROCK 抑制剂,是一种新型强效抗青光眼化合物。
021-51111890
购物车()
sales@molnova.cn

